<DOC>
	<DOCNO>NCT01289535</DOCNO>
	<brief_summary>This study first step clinical research program aim study immune response influenza vaccine elderly propose new method administer vaccine . Influenza cause severe complication patient risk ( elderly subject vulnerable chronic underlying disease ) . Over 90 % death relate influenza occur people age 65 year . Vaccination effective way prevent infection . The World Health Organization recommend annual immunization people risk , include person age 65 year , reduce risk morbidity mortality relate influenza . However , immune response influenza vaccine appear low elderly young people .</brief_summary>
	<brief_title>Immune Response Analysis Influenza Vaccine Elderly Aged Over 65 Years</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Subject age 65 year Influenza vaccination without adjuvant , within 3 week 3 month inclusion visit Legal capacity consent Subject give write consent participation Adjuvanted influenza vaccine ( e.g : Fluad , Gripguard ) Live vaccine within 3 week influenza vaccination Inactivated vaccine within 2 week influenza vaccination Chronic disease nonstabilized treatment Severe malnutrition opinion investigator Congenital immunodeficiency Chemotherapy radiotherapy last 6 month Immunosuppressive therapy corticosteroid ( daily dose prednisone equivalent &gt; /= 20 mg/d 14 day ) 1 month vaccination study visit Participation another clinical study could interfere present study</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>Influenza vaccine</keyword>
	<keyword>immune response</keyword>
	<keyword>elderly</keyword>
</DOC>